Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16172
Title: | The genetic landscape of the epileptic encephalopathies of infancy and childhood | Austin Authors: | McTague, Amy;Howell, Katherine B;Cross, J Helen;Kurian, Manju A;Scheffer, Ingrid E | Affiliation: | Austin Health, Heidelberg, Victoria, Australia Molecular Neurosciences, Developmental Neurosciences Programme, UCL Institute of Child Health, London, UK Clinical Neurosciences, Developmental Neurosciences Programme, UCL Institute of Child Health, London, UK Department of Neurology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK Department of Neurology, Royal Children's Hospital, Melbourne, Victoria, Australia Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia Neurosciences Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia Department of Medicine, Epilepsy Research Centre, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia Florey Institute of Neurosciences and Mental Health, Melbourne, Victoria, Australia |
Issue Date: | Mar-2016 | Date: | 2015-11-17 | Publication information: | Lancet Neurology 2016; 15(3): 304-316 | Abstract: | Epileptic encephalopathies of infancy and childhood comprise a large, heterogeneous group of severe epilepsies characterised by several seizure types, frequent epileptiform activity on EEG, and developmental slowing or regression. The encephalopathies include many age-related electroclinical syndromes with specific seizure types and EEG features. With the molecular revolution, the number of known monogenic determinants underlying the epileptic encephalopathies has grown rapidly. De-novo dominant mutations are frequently identified; somatic mosaicism and recessive disorders are also seen. Several genes can cause one electroclinical syndrome, and, conversely, one gene might be associated with phenotypic pleiotropy. Diverse genetic causes and molecular pathways have been implicated, involving ion channels, and proteins needed for synaptic, regulatory, and developmental functions. Gene discovery provides the basis for neurobiological insights, often showing convergence of mechanistic pathways. These findings underpin the development of targeted therapies, which are essential to improve the outcome of these devastating disorders. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16172 | DOI: | 10.1016/S1474-4422(15)00250-1 | ORCID: | 0000-0002-2311-2174 | Journal: | Lancet Neurology | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/26597089 | Type: | Journal Article | Subjects: | Brain Diseases Epilepsy |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.